Definium Therapeutics, Inc. (DFTX)
29.12
-0.26
(-0.88%)
USD |
NASDAQ |
Nov 18, 16:00
29.32
+0.20
(+0.69%)
After-Hours: 18:52
Definium Therapeutics Debt to Equity Ratio : 0.0379 for Sept. 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.0379 |
| June 30, 2026 | 0.0397 |
| March 31, 2026 | 0.1462 |
| December 31, 2025 | 0.1221 |
| September 30, 2025 | 0.3092 |
| June 30, 2025 | 0.2222 |
| March 31, 2025 | 0.0989 |
| December 31, 2024 | 0.0905 |
| September 30, 2024 | 0.0927 |
| June 30, 2024 | 0.12 |
| March 31, 2024 | 0.0724 |
| December 31, 2023 | 0.1808 |
| September 30, 2023 | 0.1466 |
| June 30, 2023 | 0.0007 |
| March 31, 2023 | 0.0006 |
| December 31, 2022 | 0.0005 |
| September 30, 2022 | 0.0005 |
| June 30, 2022 | 0.0006 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| August 31, 2019 | 0.00 |
| May 31, 2019 | 0.00 |
| February 28, 2019 | 0.00 |
| November 30, 2018 | 0.00 |
| August 31, 2018 | 0.00 |
| May 31, 2018 | 0.00 |
| February 28, 2018 | 0.0036 |
| November 30, 2017 | 0.00 |
| August 31, 2017 | 0.0044 |
| May 31, 2017 | 0.00 |
| February 28, 2017 | 0.00 |
| November 30, 2016 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Enliven Therapeutics, Inc. | 0.0015 |
| Cocrystal Pharma, Inc. | 0.4699 |
| CNBX Pharmaceuticals, Inc. | -0.4388 |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 0.0148 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.074B |
| Total Liabilities (Quarterly) | 106.25M |
| Shareholders Equity (Quarterly) | 968.03M |
| Current Ratio | 15.53 |
| Net Debt Paydown Yield | 0.02% |